Literature DB >> 23506171

Anal sphincter fibrillation: is this a new finding that identifies resistant chronic anal fissures that respond to botulinum toxin?

A Moon1, P Chitsabesan, S Plusa.   

Abstract

AIM: Anal fissures can be resistant to treatment and some patients may undergo several trials of medical therapy before definitive surgery. It would be useful to identify predictors of poor response to medical therapy. This study assesses the role of anorectal physiological criteria to identify patients with anal fissure predicted to fail botulinum toxin (BT) treatment.
METHOD: A retrospective analysis of anorectal physiological data collected for patients with resistant chronic anal fissures, referred to one consultant surgeon between 2007 and 2011, was undertaken. These were correlated with treatment plans and healing rates.
RESULTS: Twenty-five patients with idiopathic chronic anal fissures underwent anorectal physiology studies and were subsequently treated with BT injection. Eleven had a characteristic high-frequency low-amplitude 'saw tooth' waveform or anal sphincter fibrillation (ASF) and higher anal sphincter pressures. Nine (82%) of these patients had resolution of their anal fissure symptoms following treatment with BT. Of 14 patients with no evidence of ASF and a greater range of anal sphincter pressures, only one (7%) had resolution following BT.
CONCLUSION: ASF appears to be an anorectal physiological criterion that helps predict response of anal fissures to BT injection. This could help streamline fissure management.
© 2013 The Authors. Colorectal Disease © 2013 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Anal fissures; anal physiology; botulinum toxin

Mesh:

Substances:

Year:  2013        PMID: 23506171     DOI: 10.1111/codi.12212

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  1 in total

1.  Botulinum toxin improves pain in chronic anal fissure.

Authors:  Hugo Amorim; José Santoalha; Rui Cadilha; Maria-José Festas; Paula Barbosa; Armanda Gomes
Journal:  Porto Biomed J       Date:  2017-05-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.